Brasília – Brazil’s Health Minister, Alexandre Padilha (PT-SP), announced this Friday (July 25) the creation of the country’s first RNA Competence Center, focusing on messenger RNA (mRNA). The initiative is part of a package of investments in innovation in the Unified Health System (SUS), in partnership with the Pan American Health Organization (PAHO) and the Brazilian Company for Industrial Research and Innovation (Embrapii).

According to the Ministry of Health, the RNA Competence Center will aim to strengthen national capacity for the development and production of advanced biotechnological solutions, with potential applications in vaccines, treatments, and diagnostics. The investment aligns with the government’s strategy to enhance Brazil’s autonomy in health technologies, within the framework of the Health Economic-Industrial Complex (CEIS) policy.

The announcement reinforces Brazil’s commitment to expanding innovation in public health and reducing dependence on imported strategic technologies.

Source: Jota

Would you like a complete analysis on this? Contact us at pharmabrnews@gmail.com.